Shanghai Xiao Fang Pharmaceutical Co (SHSE:603207) Pre-Tax Income : ¥89.7 Mil (TTM As of Sep. 2024)

Shanghai Xiao Fang Pharmaceutical Co Pre-Tax Income Chart

Shanghai Xiao Fang Pharmaceutical Co Quarterly Data
	Dec19	Dec20	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24	Sep24
Pre-Tax Income	Get a 7-Day Free Trial							73.27	59.13	39.91	-	49.84

Competitive Comparison of Shanghai Xiao Fang Pharmaceutical Co's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Xiao Fang Pharmaceutical Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Xiao Fang Pharmaceutical Co's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Xiao Fang Pharmaceutical Co's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Shanghai Xiao Fang Pharmaceutical Co's Pre-Tax Income falls into.

Shanghai Xiao Fang Pharmaceutical Co Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Shanghai Xiao Fang Pharmaceutical Co's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Shanghai Xiao Fang Pharmaceutical Co's Pretax Income for the quarter that ended in Sep. 2024 is calculated as

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥89.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Xiao Fang Pharmaceutical Co  (SHSE:603207) Pre-Tax Income Explanation

Shanghai Xiao Fang Pharmaceutical Co's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

During the past 5 years, Shanghai Xiao Fang Pharmaceutical Co's highest Pretax Margin was 51.73%. The lowest was 38.47%. And the median was 48.59%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Xiao Fang Pharmaceutical Co Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Shanghai Xiao Fang Pharmaceutical Co's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Xiao Fang Pharmaceutical Co Business Description